Get the latest analysis on Heron Therapeutics (HRTX): current challenges, future outlook, and key growth factors. Click here ...

Pulse Biosciences ( PLSE 3.81%) reported its first revenues, marking initial commercial adoption of its nPulse platform and ...

Evaluate how FTAs, HS codes, and duty-drawback mechanisms can optimize import costs, compliance, and liquidity for foreign ...

Discover AirSculpt Technologies' Q3 2025 earnings, strategic pivots for GLP-1 users, cost controls, and North America focus.

CEO Treace stated, "we are not growing our line the way we anticipated for the year," while also noting case volume growth in ...

Between 2017 and 2024, Spain’s Socialist Workers’ Party (PSOE) transferred nearly 940,000 euros from its bank account at BBVA ...

Operator: Hello, and thank you for standing by. My name is Mark, and I will be your conference operator today.

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth.

Third quarter 2025 net loss was $ (16.3) million, or $ (0.26) per share, compared to $ (15.4) million, or $ (0.25) per share, for the same period in 2024. Adjusted EBITDA loss was $ (2.6) million in ...

Full-year 2025 guidance -- Revenue expected between $365 million-$375 million, non-GAAP gross margins of 78%-80%, non-GAAP ...

Sight Sciences ( (SGHT) ) just unveiled an announcement.

Regional Management Corp. (NYSE: RM), a diversified consumer finance company, announced today that it has completed a $253 million asset-backed securitization.